InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: suny66 post# 166434

Sunday, 12/11/2022 5:25:44 PM

Sunday, December 11, 2022 5:25:44 PM

Post# of 198709
Hopefully so! They've had two ECRM conventions to get it in front of prospective retailers.

I try to keep expectations realistic, and I've generally counted what they said about "production capability" as a cop out for a product offering they were totally unprepared to make earlier this year.

But what if they really did have unexpected demand from national retailers at ECRM? Things could get interesting fast.

Enzolytics IPF Immune will be available in numerous sales outlets throughout the U.S. Delays in producing sufficient quantiles for the market are being addressed. These delays have provided time for increasing production capability to meet demand. The company’s market research has indicated significant demand for IPF Immune.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News